SETA BioMedicals was founded in 2008 with the goal to produce and commercialize reliable, high-quality fluorescent products for the biomedical fields and to enter into strategic alliances with corporate partners.

There is still a need for novel fluorescent reagents in particular for new, emerging fluorescence applications (annual market for fluorescent reagents is in the order of over 900 million and is growing 20% annually) and some of the latest product developments of SETA BioMedicals are addressing this need.